Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- N-[4-[[4-[(4-ethoxyphenyl)amino]phenyl][4-[ethyl[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylene]-3-methyl-2,5-cyclohexadien-1-ylidene]-N-ethyl-3-sulfo-benzenemethanaminium, sodium salt
- Correlated keywords
- 25305-63-9 Dyes stains inhibitors inhibits inhibitions channels blockers neurosciences neurological injuries seondary proteins binding binds coomassie quantify quantifications gels Bradford assays rapid dye-binding binds bindings P2X purinoceptors channels P2X7 rats humans mouse mice PRX7 IL-1? interleukins interleukin-1b interleukin-1beta interleukin-1.beta. interleukin-1? IL-1b IL-1.beta. IL-1beta IL1? IL1b IL1beta IL1.beta. expressions quantifying indocyanine G indocyanine-G C.I. Acid blue 90 G 4061 G-4061 G4061 PG bright cyanine cyanine-G acidine sky blue-G amacid anadurm A-G AG BBG benzyl G250 G-250 250 J blue-J GA-CF GA CF GACF bucacid C.I. 42655 C.I.-42655 C.I.42655 CBB-G CBB colocid EG daiwa acids derma GN 360 GN-360 GN360 dycosweak eriosin fenazo XXFG impero azure kayanol lerui milling 2J NSCs 328382 NSC-328382 NSC328382 optanol orient water 105 105S 105-S S polar G01 G-01 01 polycor sandolan N-G NG N sellaset serva silk fast simacid G350 G-350 350 sumitomo supranol triacids xylene trauma traumatic brains injury
- Product Overview:
Brilliant Blue G is a dye which is commonly used in laboratories to stain or quantify proteins. A variety of methods have been developed for using Brilliant Blue G to stain gels with ease and sensitivity.{22767,22770,22766,22771} The Bradford assay is a standard, rapid dye-binding assay that uses Brilliant Blue G to quantify the amount of protein in a solution.{11189} This compound also acts as a selective inhibitor of the P2X purinoceptor channel P2X7 (IC50s = 10.1 and 265 nM for rat and human P2X7, respectively).{22768} In mice, it inhibits interleukin-1? expression and reduces neurological injury secondary to traumatic brain injury.{22769}
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.